top of page
Coyote Ventures

Coyote Ventures


    Female focused, Focus on DEI

Investment Stage: 

    Early Stage, Pre-Seed, Seed

Minimum Investment:



    Biotech, Consumer, Consumer Apps, Femtech, Health, Life Sciences, Mental Health, Sexual Wellness, Healthtech

About the firm:

Coyote Ventures invests at the intersection of consumer health and overlooked markets, starting with women's health and wellness. General Partner Jessica Karr was a Biochemist at Impossible Foods and has hands-on experience building and launching novel products. Women’s health is a $1T+ global opportunity, and is an emerging industry due to the historic marginalization and taboo of women’s health. Coyote Ventures has completed its first investments, and is actively investing to create a synergistic portfolio that addresses huge underserved areas of women's health.

Learn more about this firm by:

Accepts investors from outside the US:


bottom of page